Olmo has experience in information technology and operations senior management, following an eighteen year career as a delivery manager and application architect.
Previously, he was involved with several large financial institutions holding various positions, including chief architect and application delivery executive.
Olmo said to be able to create and facilitate, almost ‘green field’, the kind of infrastructure needed to support and accelerate the growth of Revolutions Medical’s cutting edge products in the healthcare marketplace is an exciting opportunity.
"After months of evaluating the company, I have concluded the RevVac Safety Syringe is superior technology. Furthermore, the proprietary MRI software tools now being clinically validated offer advanced imaging applications that are currently not available to the medical community," Olmo said.
Revolutions Medical products include the RevVac Safety Syringe (FDA cleared), safety blood drawing device, the RevColor, RevDisplay and Rev3D software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).
The company also has an exclusive license to a Breast Biopsy System (BBS), preliminary called RevTrack (FDA cleared).
